These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 28757050)

  • 1. Electroencephalographic, cognitive, and neurochemical effects of LY3130481 (CERC-611), a selective antagonist of TARP-γ8-associated AMPA receptors.
    Witkin JM; Li J; Gilmour G; Mitchell SN; Carter G; Gleason SD; Seidel WF; Eastwood BJ; McCarthy A; Porter WJ; Reel J; Gardinier KM; Kato AS; Wafford KA
    Neuropharmacology; 2017 Nov; 126():257-270. PubMed ID: 28757050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Blockade of TARP-γ8-Associated AMPA Receptors: Anticonvulsant Activity with the Selective Antagonist LY3130481 (CERC-611).
    Witkin JM; Schober DA; Gleason SD; Catlow JT; Porter WJ; Reel J; Jin X; Hobbs J; Gehlert D; Gernert DL; Gardinier KM; Kato AS; Ping X; Smith JL
    CNS Neurol Disord Drug Targets; 2017; 16(10):1099-1110. PubMed ID: 29090671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of TARP
    Knopp KL; Simmons RMA; Guo W; Adams BL; Gardinier KM; Gernert DL; Ornstein PL; Porter W; Reel J; Ding C; Wang H; Qian Y; Burris KD; Need A; Barth V; Swanson S; Catlow J; Witkin JM; Zwart R; Sher E; Choong KC; Wall TM; Schober D; Felder CC; Kato AS; Bredt DS; Nisenbaum ES
    J Pharmacol Exp Ther; 2019 Jun; 369(3):345-363. PubMed ID: 30910921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forebrain-selective AMPA-receptor antagonism guided by TARP γ-8 as an antiepileptic mechanism.
    Kato AS; Burris KD; Gardinier KM; Gernert DL; Porter WJ; Reel J; Ding C; Tu Y; Schober DA; Lee MR; Heinz BA; Fitch TE; Gleason SD; Catlow JT; Yu H; Fitzjohn SM; Pasqui F; Wang H; Qian Y; Sher E; Zwart R; Wafford KA; Rasmussen K; Ornstein PL; Isaac JT; Nisenbaum ES; Bredt DS; Witkin JM
    Nat Med; 2016 Dec; 22(12):1496-1501. PubMed ID: 27820603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Determinants of the γ-8 TARP Dependent AMPA Receptor Antagonist.
    Lee MR; Gardinier KM; Gernert DL; Schober DA; Wright RA; Wang H; Qian Y; Witkin JM; Nisenbaum ES; Kato AS
    ACS Chem Neurosci; 2017 Dec; 8(12):2631-2647. PubMed ID: 28825787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auxiliary subunits of AMPA receptors: The discovery of a forebrain-selective antagonist, LY3130481/CERC-611.
    Kato AS; Witkin JM
    Biochem Pharmacol; 2018 Jan; 147():191-200. PubMed ID: 28987594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 5-hydroxytryptamine4 receptor agonists prucalopride and PRX-03140 increase acetylcholine and histamine levels in the rat prefrontal cortex and the power of stimulated hippocampal θ oscillations.
    Johnson DE; Drummond E; Grimwood S; Sawant-Basak A; Miller E; Tseng E; McDowell LL; Vanase-Frawley MA; Fisher KE; Rubitski DM; Stutzman-Engwall KJ; Nelson RT; Horner WE; Gorczyca RR; Hajos M; Siok CJ
    J Pharmacol Exp Ther; 2012 Jun; 341(3):681-91. PubMed ID: 22408061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inquiries into the Biological Significance of Transmembrane AMPA Receptor Regulatory Protein (TARP) γ-8 Through Investigations of TARP γ-8 Null Mice§.
    Gleason SD; Kato A; Bui HH; Thompson LK; Valli SN; Stutz PV; Kuo MS; Falcone JF; Anderson WH; Li X; Witkin JM
    CNS Neurol Disord Drug Targets; 2015; 14(5):612-26. PubMed ID: 25921737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dual orexin receptor antagonist, DORA-22, lowers histamine levels in the lateral hypothalamus and prefrontal cortex without lowering hippocampal acetylcholine.
    Yao L; Ramirez AD; Roecker AJ; Fox SV; Uslaner JM; Smith SM; Hodgson R; Coleman PJ; Renger JJ; Winrow CJ; Gotter AL
    J Neurochem; 2017 Jul; 142(2):204-214. PubMed ID: 28444767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of human epileptic tissue in the characterization and development of novel antiepileptic drugs: The example of CERC-611 and KRM-II-81.
    Witkin JM; Ping X; Cerne R; Mouser C; Jin X; Hobbs J; Tiruveedhula VVNPB; Li G; Jahan R; Rashid F; Kumar Golani L; Cook JM; Smith JL
    Brain Res; 2019 Nov; 1722():146356. PubMed ID: 31369732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the rat.
    Woolley ML; Waters KA; Gartlon JE; Lacroix LP; Jennings C; Shaughnessy F; Ong A; Pemberton DJ; Harries MH; Southam E; Jones DN; Dawson LA
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):343-54. PubMed ID: 18795266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo pharmacological profile of S 38093, a novel histamine H3 receptor inverse agonist.
    Panayi F; Sors A; Bert L; Martin B; Rollin-Jego G; Billiras R; Carrié I; Albinet K; Danober L; Rogez N; Thomas JY; Pira L; Bertaina-Anglade V; Lestage P
    Eur J Pharmacol; 2017 May; 803():1-10. PubMed ID: 28315340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral impairments and serotonin reductions in rats after chronic L-dopa.
    Stansley BJ; Yamamoto BK
    Psychopharmacology (Berl); 2015 Sep; 232(17):3203-13. PubMed ID: 26037945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of the First α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist Dependent upon Transmembrane AMPA Receptor Regulatory Protein (TARP) γ-8.
    Gardinier KM; Gernert DL; Porter WJ; Reel JK; Ornstein PL; Spinazze P; Stevens FC; Hahn P; Hollinshead SP; Mayhugh D; Schkeryantz J; Khilevich A; De Frutos O; Gleason SD; Kato AS; Luffer-Atlas D; Desai PV; Swanson S; Burris KD; Ding C; Heinz BA; Need AB; Barth VN; Stephenson GA; Diseroad BA; Woods TA; Yu H; Bredt D; Witkin JM
    J Med Chem; 2016 May; 59(10):4753-68. PubMed ID: 27067148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the dorsomedial part of the prefrontal cortex serotonergic innervation in rat responses to the aversively conditioned context: behavioral, biochemical and immunocytochemical studies.
    Lehner M; Taracha E; Turzyńska D; Sobolewska A; Hamed A; Kołomańska P; Skórzewska A; Maciejak P; Szyndler J; Bidziński A; Płaźnik A
    Behav Brain Res; 2008 Oct; 192(2):203-15. PubMed ID: 18499280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SB-399885 is a potent, selective 5-HT6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models.
    Hirst WD; Stean TO; Rogers DC; Sunter D; Pugh P; Moss SF; Bromidge SM; Riley G; Smith DR; Bartlett S; Heidbreder CA; Atkins AR; Lacroix LP; Dawson LA; Foley AG; Regan CM; Upton N
    Eur J Pharmacol; 2006 Dec; 553(1-3):109-19. PubMed ID: 17069795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AC260584 (4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one), a selective muscarinic M1 receptor agonist, increases acetylcholine and dopamine release in rat medial prefrontal cortex and hippocampus.
    Li Z; Bonhaus DW; Huang M; Prus AJ; Dai J; Meltzer HY
    Eur J Pharmacol; 2007 Oct; 572(2-3):129-37. PubMed ID: 17628522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of chronic administration of ethosuximide on learning and memory: a behavioral and biochemical study on nonepileptic rats.
    Ponnusamy R; Pradhan N
    Behav Pharmacol; 2006 Nov; 17(7):573-80. PubMed ID: 17021389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JNJ-10181457, a selective non-imidazole histamine H(3) receptor antagonist, normalizes acetylcholine neurotransmission and has efficacy in translational rat models of cognition.
    Galici R; Boggs JD; Aluisio L; Fraser IC; Bonaventure P; Lord B; Lovenberg TW
    Neuropharmacology; 2009 Jun; 56(8):1131-7. PubMed ID: 19345233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a positive allosteric modulator of group II metabotropic glutamate receptors, LY487379, on cognitive flexibility and impulsive-like responding in rats.
    Nikiforuk A; Popik P; Drescher KU; van Gaalen M; Relo AL; Mezler M; Marek G; Schoemaker H; Gross G; Bespalov A
    J Pharmacol Exp Ther; 2010 Dec; 335(3):665-73. PubMed ID: 20739457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.